KISSEI PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,585 JPY | +1.41% |
|
+4.82% | +16.02% |
| 03-20 | Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program | MT |
| 03-19 | Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. | CI |
ETFs positioned on Kissei Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.26% | 15 M€ | +7.34% | ||
| 0.02% | 18 M€ | +16.15% | - | |
| 0.01% | 66,066 M€ | +14.68% | - | |
| 0.01% | 144,586 M€ | +14.49% | ||
| 0.01% | 20,721 M€ | +13.52% | - | |
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +2.14% | - |
KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
Sector
Pharmaceuticals
Calendar
06/05/2024
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3,585
JPY
Average target price
3,833
JPY
Spread / Average Target
+6.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.02% | 1.01B | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B | |
| +3.90% | 1.65B |
- Stock Market
- Equities
- 4547 Stock
- Funds and ETFs Kissei Pharmaceutical Co., Ltd.
